New Jersey Medical Cannabis Foundational Certification

No Reviews Available

Learn From the Leader in Global Medical Cannabis Education

$160.00
Enroll Now

The New Jersey Medical Cannabis Foundational Certification consists of 11 educational modules designed to teach dispensary personnel and medical professionals about cannabis. Learn about the legal framework surrounding cannabis in New Jersey to US policy at large. Then, discover the fundamentals of the cannabis plant and learn about the Endocannabinoid System (ECS) and how cannabis works in our bodies. This course, which includes video explanations from medical experts and engaging infographics, will provide value to anyone wanting to better understand the science and utilization of cannabis.

If you are a dispensary, medical group, or company and interested in multi-seat pricing or a customized, white label course, please call 844.411.0500.

Learn From the Most Comprehensive Cannabis Education Materials on the Market

No Ratings Currently Available

$160.00

Enroll Now

Does your state have legal cannabis?

Yes! Medical Cannabis and Adult Use is legal in New Jersey. New Jersey became the 14th US state to legalize marijuana for medical use when the Legislature passed the New Jersey Compassionate Use Medical Marijuana Act (CUMMA), also known as S 88, in January 2010. It was signed into law by Gov. Jon Corzine on January 18, 2010, but stalled when Gov. Chris Christie took office the next day. New Jersey’s medical marijuana patient registry reopened on August 9, 2012, and began allowing registered physicians to initiate patient certifications with the Medical Marijuana Program (MMP).

On April 21, 2022, the New Jersey adult-use cannabis market officially opened. In March 2022, the New Jersey Cannabis Regulatory Commission (CRC) approved licenses for seven alternative treatment centers to allow sales of adult-use cannabis products to adults 21 and older without a medical card. The CRC authorized 13 individual dispensaries to begin operations on April 21.

Under guidance issued by the CRC, medical patients may purchase up to three ounces every 30 days, while adult-use consumers can purchase up to one ounce per transaction. Source: MPP

Where to start?

Our certification programs span from Washington state to New York, and every legal state in between. The Medical Cannabis Foundational Certification will allow you to learn the core fundamentals of cannabis science and explore cannabis industry knowledge, so you are prepared to be a certified hire in your Montana. Our courses and certifications will provide you with knowledge and skillset to enter the cannabis job market competitively, right out of the gate.

Get certified by the best cannabis education company, Medical Marijuana 411 (MM411 Inc).

What does the Medical Cannabis Foundational Certification Include?

The Medical Cannabis Foundational Certification will allow you to learn the core fundamentals of cannabis science and explore cannabis industry knowledge, so you are prepared to be a certified in your state. Our courses and certifications will provide you with knowledge and skillset to enter the cannabis job market competitively, right out of the gate. This certification is not just for medical professionals, but for budtenders who want to enroll in the most robust cannabis certification course as your educational foundation.

As you expand your cannabis educational pursuits, make sure to check out additional courses such as our Advanced CBD Certification. Medical Marijuana 411 will be adding new expert level certifications monthly. Subscribe to our e-news to stay informed!

The Medical Cannabis Foundational Course is an online course that covers a series of 12 modules designed to teach healthcare and industry professionals the fundamental topics of cannabis and includes a specific module on the legal framework, forms and other pertinent information regarding the New Jersey Cannabis Commission and framework.

In addition to New Jersey Cannabis regulations, including the historic Jake Honig case which is now referred to as “Jake’s Law”,  you will learn about the federal legal framework of working with medical marijuana patients, the basics of the cannabis plant, the Endocannabinoid System, and how cannabinoid receptors work with our bodies. Additional modules will cover important topics like: how to medicate, inhalation versus ingestion, contraindications, drug-on-drug interactions, and recommended rations of specific illnesses.

Did you know that Healthcare Professionals are covered by Federal Law to talk to patients about Medical Marijuana even in non-legal states by an existing statute? That’s the wealth of information contained in MM411, Inc. certifications.

This certification also  includes: video testimonials from scientists and medical experts, downloadable infographics, additional visuals to support the written content followed by an exam to receive your certificate. Any individual wanting to learn more about the science of cannabis will find the course valuable. And we guarantee your complete satisfaction or your money back. To date, MM411, Inc has never had a return. Enrollees love our certifications and we stand by our courses with a 100% guarantee.

If you are a dispensary, medical group, or company and interested in multi-seat pricing or a customized, white label course, please call 844.411.0500.

New Jersey– Therapeutic Cannabis Program (TCP) Legal Overview

On June 2, 2019, Gov. Phil Murphy signed A20, also known as Jake’s Law — named after Jake Honig, a pediatric patient who used medical cannabis during his battle with cancer. The law institutes many much needed reforms to the medical cannabis program, including:

  • expanding qualifying conditions, including by adding chronic pain;
  • providing anti-discrimination protections, including related to education, rental housing, professional licensing, and employment;
  • expanding access, including by increasing the number of cultivators, retailers, and manufacturers; and
  • allowing home delivery.

A more detailed summary of the changes can be found here.

Medical professionals recommending medical cannabis must hold an active New Jersey medical license in good standing issued by the NJ Board of Medical Examiners, possess an active controlled dangerous substances registration issued by the NJ Division of Consumer Affairs that is not subject to limitation, and practice within the State of New Jersey.

Physicians must have a bona fide physician-patient relationship with a patient in order to register them with the program. A bona fide physician-patient relationship means a relationship in which the physician has ongoing responsibility for the assessment, care and treatment of a patient’s debilitating medical condition whereby:

  • The physician-patient relationship has existed for at least one year; or
  • The physician has seen and/or assessed the patient for the debilitating medical condition on at least four visits; or
  • The physician assumes responsibility for providing management and care of the patient’s debilitating medical condition after conducting a comprehensive medical history and physical examination, including a personal review of the patient’s medical record maintained by other treating physicians reflecting the patient’s reaction and response to conventional medical therapies.

Only physicians that are registered with the Medicinal Marijuana Program (MMP) can certify patients to receive medicinal marijuana. You can register on the New Jersey MMP website. A physician must initiate a patient registration for the program.

Source: Americans For Safe Access

Recreational or adult-use cannabis became legal in New Jersey from Jan 1, 2021, after the Marijuana Legalization Amendment was approved by voters during the general elections in November 2020 with 67% voting in favor.  On April 21, 2022, the New Jersey adult-use cannabis market officially opened. In March 2022, the New Jersey Cannabis Regulatory Commission (CRC) approved licenses for seven alternative treatment centers to allow sales of adult-use cannabis products to adults 21 and older without a medical card. The CRC authorized 13 individual dispensaries to begin operations on April 21. 

Under guidance issued by the CRC, medical patients may purchase up to three ounces every 30 days, while adult-use consumers can purchase up to one ounce per transaction.

Qualifying Conditions

  • Amyotrophic lateral sclerosis
  • Anxiety
  • Cancer
  • Chronic pain
  • Dysmenorrhea
  • Glaucoma
  • Inflammatory bowel disease, including Crohn’s disease
  • Intractable skeletal muscular spasticity
  • Migraine
  • Multiple sclerosis
  • Muscular dystrophy
  • Opioid Use Disorder
  • Positive status for Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS)
  • Post-Traumatic Stress Disorder (PTSD)
  • Seizure disorder, including epilepsy
  • Terminal illness with prognosis of less than 12 months to live
  • Tourette Syndrome

Opioid use disorder qualifies as a standalone debilitating medical condition for the program.  Opioid use disorder patients may be eligible for medical cannabis to treat the opioid disorder itself, or if they suffer from chronic, painful withdrawal symptoms.

Course Syllabus

Module 1 – US Legal

  • U.S. Controlled Substances Act
  • Drug Schedule – Cannabis Schedule I
  • Drug Schedule (Graphic)
  • COVID Cannabis Guidelines
  • Economic Impact
  • Cannabis genus of flowering plants in the family Cannabaceae
  • Legal differentiation between hemp and marijuana distinguished by their respective concentrations of the cannabinoid delta-9 tetrahydrocannabinol (THC)
  • 2018 Farm Bill
    • Impact on hemp classification
  • SAFE Banking Act
  • U.S. Pat. No. 6,630,507
  • Trademarks
  • Ogden Memo
  • Cole Memo
  • Wilkenson Memo
  • 2018 Sessions Memorandum
  • Rohrabacher–Blumenauer Amendment
  • Joyce Amendment
  • Conant v. Walters
  • What Medical Professionals Can Legally Provide To Their Patients (Graphic)
  • Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research
  • Guidance for Industry – Downloadable PDf
  • Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research
  • Guidance for Industry – Video Explainer
  • Taxes
  • Affirmative Defense
  • Bankruptcy Protection
  • Employment Law
  • Access to Banking  – Financial Crimes Enforcement Network FinCEN Guidance
  • Copyright and Registration

Module 2 – New Jersey  Medical Cannabis and Adult Use Cannabis Legal which includes “Jake’s Law” 

Module 3 – History

  • Early History of Cannabis Use
  • Cannabis in the West
  • U.S. Prohibition History
  • The Medical Implications of U.S. Prohibition
  • Medical Cannabis Today
  • Hemp vs Cannabis
  • Brief Chronology of History in Spain and throughout Europe

Module 4 – The Discovery of the Endocannabinoid System

  • Introduction of the Endocannabinoid System (ECS)
  • Largest Receptor System
  • ECS – Video Explainer
  • Newly Discovered
  • Chemical Bridge to All Bodily Functions
  • Homeostasis
  • Healthy Body = Healthy ECS
  • ECS – Downloadable Graphic
  • Dr Jake Felice – What is the Endocannabinoid System (ECS)? Video Interview
  • Largest Neurotransmitter System of all “the body’s supercomputer”
  • 1964 discovery of THC and CBD – Raphael Mechoulam, Ph.D and Yehiel Gaoni, Ph.D
  • The Scientist – video regarding Raphael Mechoulam, Ph.D discoveries
  • Allyn Howlett, Ph.D  – Isolating THC in the brain – 1998
    • No cannabinoid receptors in the cardiac and respiratory centers of the brainstem therefore no overdose from cannabis
  • Raphael Mechoulam, Ph.D found in 1992, brain chemical that mirrors the effects of THC
    • Two brain chemicals – anandamide, Sanskrit word “ananda” brain chemical that mimics THC and CBD, 2-Arachidonoylglycerol, which they named 2-AG.
  • Endogenous Molecules “endocannabinoids”.
  • CB1 receptors, and CB2 receptors
  • Cannabinoids and how they attach to receptors
  • CB1 receptors
    • Located in the central nervous system and affect many brain functions including movement, anxiety, stress, fear, pain, appetite, reward, and motor control
  • CB2 receptors
    • CB2 receptors control the release of cytokines, immuno-regulatory proteins, that are linked to inflammation during illness or after injury.
  • Retrograde Inhibition
  • Lack of education on the Endocannabinoid System
  • Clinical Studies
  • At a Glance – Downloadable Infographic
  • Homeostatsis
  • Human Thriving Behavior and the ECS

Module 5 – One Plant, One Complex Chemical Factory

  • Minor Cannabinoids: CBG CBC CBN THCV
  • Terpenes
  • The Entourage Effect & Tolerance / ECS Down Regulation
  • Botanical vs. Single Molecule Compounds & Cannabinoids and Opioids

Module 6 – Getting Cannabinoids into the Bloodstream

  • Inhalation: Smoking vs. Vaporization
  • In the News Discussions
  • Cannabis Flower vs. Concentrate
  • Different Concentrate Consistencies
  • Extraction Methods
  • Winterization
  • Concentrates Using Solvents
  • Solventless Concentrates
  • Edibles, Oral Mucosal, Topicals and Suppositories
  • The Role of the Medical Provider
  • The Role of the Dispensary: Experts within the Dispensary

Module 7 – Patient Centered Dosing

  • Considerations Before Medicating with Cannabis
  • Set and Setting
  • Drug-Drug Interactions
  • Relative Contraindications
  • Youth Under 25
  • Patients and Cardiac Conditions
  • Patients with Psychiatric Diagnoses
  • Immunocompromised Patents
  • Biphasic Effect
  • Finding the Appropriate Dose
  • Recommended Ratios for Specific Illnesses

 Module 8 – Laboratory Testing

  • How Testing Works
  • Contaminants: Pesticides, Fungi and Mold
  • How to Interpret a Test

Module 9 – Clinical Practice

  • Anxiety Disorders
  • Cancer
  • Epilepsy
  • Gastrointestinal Disorders
  • Glaucoma
  • HIV/AIDS
  • Migraine Headaches
  • Multiple Sclerosis
  • Neurodegenerative Disorders
  • Neuropathy
  • Pain
  • Palliative Care
  • Parkinson’s Disease
  • Post Traumatic Stress Disorders
  • Sleep Disorders
  • Traumatic Brain Injury (TBI)
  • Endometriosis
  • Premenstrual Syndrome and Premenstrual Dysphoric Disorder
  • Menopause

Module 10 – Cannabis and Opioids

  • Pain Management Today
  • Cannabis and Opioids: The Good News
  • Cannabis and NSAIDS: More Good News

Module 11 – Medical Myths and Facts

  • Gateway Theory, Addiction and Brain Function
  • Impaired Motivation, Memory and Mental State
  • Lung Damage, Usage Patterns and Overall Danger

Module 12 – Side Effects Abuse and Misuse

  • Cannabinoid Hyperemesis Syndrome
  • Cannabis Use Disorder (CUD)
  • Short and Long Term Side Effects
  • Physical and Mental Effects
  • Cannabis and driving
  • Cannabis Overconsumption and Tolerance

Cited Experts

With over 800+ current, peer reviewed citations, Medical Marijuana 411 is proud to be the global leader in online medical marijuana education for patients, medical professionals and cannabis dispensary consultants.

View all of our Cited Experts

Additional videos from leading cited cannabis experts, scientists and physicians, and downloadable graphics are part of this certification. Here is a partial list of the scientists, researchers, educators and lawyers whose work is cited within the Medical Marijuana 411 certifications.

Our goal of creating the most current content for this cannabis certification course was obtained by using peer-reviewed research from industry experts. All citations utilized in this course meet standard guidelines and are part of the public domain. Experts listed below are not affiliated with Medical Marijuana 411 and no endorsement or authorization should be inferred by their inclusion on our website. Medical Marijuana 411 has included links to each expert to ensure credit is given for their research, legal and scientific studies under the guidelines of “Fair Use.”